Jonathan Thon, PhD
CEO, Chief Scientific Officer, Co-Founder
Prior to founding Platelet BioGenesis, Jonathan was an Assistant Professor at Brigham and Women’s Hospital and Harvard Medical School, where he retains an academic affiliation. Jonathan received his Ph.D. in Biochemistry and Molecular Biology from the University of British Columbia, Canada, where he worked closely with Canadian Blood Services for the improvement of the processing and storage of blood platelets. Jonathan co-developed PBG’s bio-mimetic microfluidic platform to generate human platelets.
Sven Karlsson, CFA, MBA
Chief Business Officer, Co-Founder
Sven has a decade of experience working across venture capital, business development, and finance. Prior to founding Platelet BioGenesis, Sven worked in Mergers & Acquisitions at J.P. Morgan, as an Analyst at a hedge fund, and as a Senior Manager of Investments at a venture fund. Sven received a B.S. in Engineering from Cornell University and an MBA with Distinction from New York University’s Stern School of Business.